Nutraceutix(nutx .96) inhibits lung cancer! News story Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Nutraceutix(nutx .96) inhibits lung cancer! News story

NUTX 121.34

-7.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Barry Rost who wrote (11)	9/9/1997 5:57:00 PM
From: Rite Aid	of 57

The nutriceuticals market is a major growth area, but recognition is low and rising. See the article in today's "New York Times" on St. Johns Wart which outsells Prozac 4 to 1 in Germany. It's in the science section. Alternative medecine and the use of nutriceuticals is very commonplace in Europe and gaining acceptance in the Northwestern USA medical schools. I understand that the Texas U. medical school has done considerable development of Calcium D Glucarate and has passed favorably on its suitability. Given all this evidence I have to think that this development can be of great importance to NUTX and to people all around the world.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next